Akrivia Health
Akrivia Health is a UK-based company specializing in real-world data and AI-powered NLP solutions for mental health and dementia research. It offers a proprietary platform with the world's largest structured psychiatric dataset, enabling drug discovery, clinical trial optimization, and precision neuroscience. The company supports pharmaceutical, biotechnology, and healthcare organizations by providing data-driven insights for clinical trial feasibility, patient recruitment, post-launch evaluation, market access, and early-stage drug discovery. Akrivia Health's business model includes SaaS and subscription services, leveraging its AI and data enrichment technology to accelerate R&D and improve patient outcomes globally. It has strong NHS partnerships and a significant dataset of over 4.6 million de-identified patient records and 17 billion data points, positioning it as a leader in mental health and dementia real-world evidence generation.
Akrivia Health
Akrivia Health is a UK-based company specializing in real-world data and AI-powered NLP solutions for mental health and dementia research. It offers a proprietary platform with the world's largest structured psychiatric dataset, enabling drug discovery, clinical trial optimization, and precision neuroscience. The company supports pharmaceutical, biotechnology, and healthcare organizations by providing data-driven insights for clinical trial feasibility, patient recruitment, post-launch evaluation, market access, and early-stage drug discovery. Akrivia Health's business model includes SaaS and subscription services, leveraging its AI and data enrichment technology to accelerate R&D and improve patient outcomes globally. It has strong NHS partnerships and a significant dataset of over 4.6 million de-identified patient records and 17 billion data points, positioning it as a leader in mental health and dementia real-world evidence generation.
TL;DR
Headquarters: Oxford, United Kingdom
Focus: AI-curated real-world data and analytics for mental health, dementia and CNS R&D
Dataset scale: Claims 4.6M+ de-identified patient records (company sites cite up to 6.3M NHS records)
Business model: SaaS and subscription services for pharma/biotech partners
Founding: 2019; University of Oxford / NHS spin-out